Abstract
Hypothyroidism is characterized by cognitive and metabolic slowing, presenting as fatigue, weight gain, cold intolerance, and constipation. It is commonly diagnosed via serum TSH and free T4 tests, with standard treatment involving synthetic levothyroxine (LT4), which converts to T3 in the body to alleviate symptoms. LT4 therapy is monitored through TSH levels to restore thyroid homeostasis. However, many patients on LT4 with normalized TSH continue to experience unresolved symptoms like fatigue, mood disturbances, and reduced quality of life. Persistent symptoms may arise from misdiagnosis, as up to one-third of LT4-treated individuals may not have true hypothyroidism. Furthermore, approximately half of LT4-treated patients show abnormal thyroid hormone levels despite controlled TSH, which could explain metabolic discrepancies like higher cholesterol and slower metabolic rates. These findings have spurred interest in combining T3 (triiodothyronine) with LT4 therapy. Some patients may struggle to convert T4 into T3 effectively, causing persistent symptoms even when TSH is normalized. Adding T3 aims to address this by supplying the active hormone directly, potentially improving symptom resolution for such individuals. Randomized controlled trials comparing combined LT4 and T3 therapy to LT4 alone have shown both treatments are equally safe and effective. However, patients with residual symptoms on LT4 often report improved mood, energy, and cognitive function with added T3. These results emphasize the need for a personalized approach to hypothyroidism management, given the variability in patient responses. Shared decision-making is critical in addressing this complexity. By fostering open dialogue about symptoms, treatment goals, and potential benefits or risks, healthcare providers can tailor therapies to individual needs. Prioritizing patient experiences alongside clinical evidence can enhance symptom management, quality of life, and overall satisfaction with care.
| Original language | English (US) |
|---|---|
| Title of host publication | Principles of Precision Hormone Therapy |
| Subtitle of host publication | Healthy Aging and Prevention of Chronic Disease |
| Publisher | Springer Science+Business Media |
| Pages | 435-446 |
| Number of pages | 12 |
| ISBN (Electronic) | 9783031896507 |
| ISBN (Print) | 9783031896491 |
| DOIs | |
| State | Published - Jan 1 2025 |
Keywords
- Deiodinase
- Hypothyroidism
- Precision thyroid hormone therapy
- Triiodothyronine
ASJC Scopus subject areas
- General Medicine
- General Immunology and Microbiology
- General Agricultural and Biological Sciences